Navigation Links
Potato blight pathogenicity explained by genome plasticity

t breeders to obtain resistant varieties by introducing R genes, either by classical breeding or by genetic modification, may be a waste of time and resources when the genome dynamics of the pathogen population is not understood," says Govers. "Monitoring field populations of plant pathogens at the genome level will be instrumental for predicting the durability of R genes in crop plants."


'"/>

Source:Cold Spring Harbor Laboratory


Page: 1 2 3

Related biology news :

1. Researchers find gene that may be at root of potato blight
2. Lethal needle blight epidemic may be related to climate change
3. Cats indifference towards sugar explained
4. Pleasing plant shapes explained by new computer model
5. Evolution of irreducible complexity explained
6. Man and mouse share genome structures
7. Whole genome fine map of rice completed
8. Study finds more than one-third of human genome regulated by RNA
9. A bacterial genome reveals new targets to combat infectious disease
10. Scientists decipher genome of fungus that can cause life-threatening infections
11. Highly adaptable genome in gut bacterium key to intestinal health

Post Your Comments:
(Date:11/4/2009)... CARLSBAD, Calif., Nov. 4 GenVault...illiam Brody, M.D., Ph.D., has joined its Board of...ial Chair of the Salk Institute, is an acclaimed p...o joining the Salk Institute, Dr. Brody served as ...a member of the National Academy of Engineering an...
(Date:11/3/2009)...DISON, WI, NOVEMBER 4, 2009 -- The world,s greate...ng grape variety, human input, and something calle...eyard site, soil, and climate. , Experts will ...n a symposium on Wednesday, Nov. 4 in Pittsburgh. ... presented in two parts at the 2009 Annual Meeting...
(Date:11/3/2009)... white shark may be the ultimate loner of the ocea... but a team of researchers has discovered that the...of migration that over tens of thousands of years ... have separated themselves into a population genet.... , "White sharks are a large, highly mobile spe...
Breaking Biology News(10 mins):Dr. William Brody, President of the Salk Institute for Biological Studies, Appointed to GenVault's Board of Directors 2Dr. William Brody, President of the Salk Institute for Biological Studies, Appointed to GenVault's Board of Directors 3Great wines come from great soils 2Tags reveal white sharks have neighborhoods in the north Pacific, say Stanford researchers 2Tags reveal white sharks have neighborhoods in the north Pacific, say Stanford researchers 3Tags reveal white sharks have neighborhoods in the north Pacific, say Stanford researchers 4Broncus Technologies Exhale Stent and Other New Devices to Prompt Robust Growth In Emphysema Treatment Market According to Millennium Research Group 49010 1Broncus Technologies Exhale Stent and Other New Devices to Prompt Robust Growth In Emphysema Treatment Market According to Millennium Research Group 49010 2Sunesis to Present at the Jefferies 3rd Annual Healthcare Conference 12643 1Scottsdale Facility to Be First in U S to Showcase True REST Technology 4597 1Scottsdale Facility to Be First in U S to Showcase True REST Technology 4597 2Scottsdale Facility to Be First in U S to Showcase True REST Technology 4597 3
...of the first trial of the effect of male circumcis...andmark trial," will be published in PLoS Medicin...n reduced the rate of new infections among heteros...e HIV infection rates are generally lower among Af...ractice, compared with largely non-circumcised pop...
... Linda Gill Heart Institute at the University of K...clotting therapy. The drug and its antidote are be...g blood clots while at the same time providing phy... of the blood thinner to help safeguard patients a...on patients are prescribed so-called "blood thinne...
...r Medicine uses PET, radiotracer to track enzyme i... to reduce a key enzyme in the lungs, possibly con...effects, according to a study published in the Sep...he study, which used a radiotracer to track the en...ation of the tracer in the bloodstream than nonsmo...
Other Biology News:PLoS Medicine publishes first trial of effect of male circumcision on HIV infection 2PLoS Medicine publishes first trial of effect of male circumcision on HIV infection 3UK is first to administer new anti-clotting technology 2Smoking damages key regulatory enzyme in the lung 2Smoking damages key regulatory enzyme in the lung 3
(Date:11/6/2009)...CALGARY, Nov. 6 /PRNewswire-FirstCall/ - Oncolytic..." or the "Company") today announced updated result... in patients with sarcomas metastatic to the lung ...tive Tissue Oncology Society Meeting held in Miami...ter presentation, entitled "A Phase II Study of In...
(Date:11/6/2009)... The agenda for Arrowhead&rsquo...nce, which is set to take place on February 22-24,... three day conference we will highlight key issues...ers to share their experiences. , ...-- The agenda for Arrowhead’s 2010 Personal...
(Date:11/5/2009)...GAITHERSBURG, Md., Nov. 5 /PRNewswire-FirstCall/ -...s financial results for the third quarter ended Se....6 million ($0.04 per share) for the three months ... $6.8 million ($0.08 per share) in the comparable ...er 30, 2009, GenVec,s net loss was $14.1 million (...
(Date:11/5/2009)...PARSIPPANY, N.J., Nov. 5 DSM Pharm...e a manufacturing alliance with Galenix, Saint Jea... commercial scale manufacturing partner for Galeni... and Galenix will collaborate on business developm...ry technologies, based on the strength of Galenix ...
Breaking Biology Technology:Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 2Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 3Leaders in Biopharma and Molecular Diagnostics to Discuss Key Issues and Opportunities in Forming Partnerships at 2010 Personalized Medicine Partnerships Conference 2Leaders in Biopharma and Molecular Diagnostics to Discuss Key Issues and Opportunities in Forming Partnerships at 2010 Personalized Medicine Partnerships Conference 3GenVec Reports Third Quarter 2009 Financial Results 2GenVec Reports Third Quarter 2009 Financial Results 3GenVec Reports Third Quarter 2009 Financial Results 4GenVec Reports Third Quarter 2009 Financial Results 5GenVec Reports Third Quarter 2009 Financial Results 6DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 2DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 3
...sident of Finance -, HOPKINTON, Mass., April 3, 2...today announced the promotion of Peter F.,McAree t...r. McAree,previously served as Vice President of F...ns will step down from the position of CFO., McAr...and public,accounting experience. Previously, McAr...
...e Israeli,scientists, in a recent survey on creati...ds that could "put them into a creative state and ...ponsored by the,Jerusalem-based Project Mind Found...urprisingly revealed that, even when the issue of ...essed a medium or high level of,willingness to try...
...ics, Inc. (Nasdaq: PCYC ) today announced multipl...ne disease drug candidates at the,American Associa...g being,held April 12-16, 2008, at the San Diego C...tations relate to the company,s histone deacetylas...hase 1 clinical trial, and the,use of proprietary ...
Other Biology Technology:Caliper Life Sciences Appoints Peter F. McAree Senior Vice President and Chief Financial Officer 2Project Mind Survey of Israeli Ph.D. Scientists Favors a New Standard of Creativity in Science 2Project Mind Survey of Israeli Ph.D. Scientists Favors a New Standard of Creativity in Science 3Pharmacyclics Announces Multiple Presentations at the American Association for Cancer Research Annual Meeting 2Pharmacyclics Announces Multiple Presentations at the American Association for Cancer Research Annual Meeting 3Pharmacyclics Announces Multiple Presentations at the American Association for Cancer Research Annual Meeting 4
Armenian Hamster Anti-Mouse CD48 Monoclonal Antibody, Biotin Conjugated, Clone HM48-1 from BioLegend
Mouse Anti-Human Myeloid Marker Monoclonal Antibody, Unconjugated, Clone BM-1 from Santa Cruz Biotechnology, Inc.
Mouse Anti-Pim-1 Monoclonal Antibody, Unconjugated, Clone 12H8 from Santa Cruz Biotechnology, Inc.
Canine IL-4 ELISpot Kit from R&D Systems
Biology Products: